Pfizer Paclitaxel Injectable

The Pfizer Paclitaxel Injectable offers a trusted solution for oncology treatments, delivering an efficient approach to chemotherapy. Available in three convenient sizes—16.7 ml, 5 ml, and 50 ml vials—this injectable form features a concentration of 6 mg/ml, ensuring precise dosing for various patient needs. The Onco-Tain™ glass fliptop vials enhance the medication's stability and safety, ensuring optimal preservation and ease of access.

Paclitaxel Injectable is a staple in cancer care, providing significant benefits when used in combination therapy, especially for cancers such as ovarian, breast, and non-small cell lung cancer. Healthcare professionals appreciate the convenient packaging and multiple dose usability, which optimizes dosing and minimizes waste, making it an integral part of efficient oncology treatment routines.

• Paclitaxel's enhanced formula is delivered in convenient Onco-Tain™ glass fliptop vials, which ensure both safety and stability during storage and handling.
• Multiple dose vial feature extends usability, allowing healthcare professionals to use the exact amount needed, reducing waste and improving cost-efficiency.

• Paclitaxel Injectable is primarily used for treating various types of cancers, including ovarian, breast, and lung cancer. It is often used in combination with other chemotherapy medications to enhance its cancer-fighting efficacy.

1. What types of cancer can Paclitaxel Injectable treat?
Paclitaxel Injectable is used to treat various cancers, notably ovarian, breast, and non-small cell lung cancer. It may also be employed for other cancers as prescribed by a healthcare professional.

2. How is Paclitaxel administered?
Paclitaxel is administered intravenously, often in a hospital or clinic setting under the supervision of a healthcare professional.